JPS5395989A - Substituted 11thienyl and furyll 2*3*4*55tetrahydroo1hh33benzazepine compound - Google Patents

Substituted 11thienyl and furyll 2*3*4*55tetrahydroo1hh33benzazepine compound

Info

Publication number
JPS5395989A
JPS5395989A JP981278A JP981278A JPS5395989A JP S5395989 A JPS5395989 A JP S5395989A JP 981278 A JP981278 A JP 981278A JP 981278 A JP981278 A JP 981278A JP S5395989 A JPS5395989 A JP S5395989A
Authority
JP
Japan
Prior art keywords
11thienyl
furyll
substituted
compound
substituted 11thienyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP981278A
Other languages
English (en)
Other versions
JPS6341912B2 (ja
Inventor
Jiyooji Hooruden Kenesu
Chiifuai Imu Neruson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
SmithKline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Corp filed Critical SmithKline Corp
Publication of JPS5395989A publication Critical patent/JPS5395989A/ja
Publication of JPS6341912B2 publication Critical patent/JPS6341912B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP981278A 1977-02-02 1978-01-30 Substituted 11thienyl and furyll 2*3*4*55tetrahydroo1hh33benzazepine compound Granted JPS5395989A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/764,672 US4111957A (en) 1977-02-02 1977-02-02 Substituted 1-thienyl and furyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds

Publications (2)

Publication Number Publication Date
JPS5395989A true JPS5395989A (en) 1978-08-22
JPS6341912B2 JPS6341912B2 (ja) 1988-08-19

Family

ID=25071413

Family Applications (2)

Application Number Title Priority Date Filing Date
JP981278A Granted JPS5395989A (en) 1977-02-02 1978-01-30 Substituted 11thienyl and furyll 2*3*4*55tetrahydroo1hh33benzazepine compound
JP61288630A Pending JPS62161764A (ja) 1977-02-02 1986-12-03 ベンズアゼピン化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP61288630A Pending JPS62161764A (ja) 1977-02-02 1986-12-03 ベンズアゼピン化合物

Country Status (6)

Country Link
US (1) US4111957A (ja)
JP (2) JPS5395989A (ja)
BE (1) BE868868A (ja)
DE (1) DE2804285A1 (ja)
FR (2) FR2379534A1 (ja)
GB (1) GB1599705A (ja)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352754A (en) * 1976-11-17 1982-10-05 Smithkline Corporation 3-Thienylmethyl-6-halo-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
JPS5481290A (en) * 1977-11-17 1979-06-28 Smithkline Corp Benzazepin compound
ZA792785B (en) * 1978-07-07 1980-08-27 Smithkline Corp Mercapto substituted-2,3,4,5-tetrahydro-1h-3-benzazepines
US4282146A (en) * 1978-11-20 1981-08-04 Pennwalt Corporation Preparation of 1,2,4,5-tetrahydro-7-alkoxy-(and 7,8-dialkoxy)-3H,3-benzazepines and 3-substituted derivatives thereof from the corresponding phenethylamines
US4255445A (en) * 1980-03-07 1981-03-10 Smithkline Corporation 8-Hydroxy-6,7-(2-methyl-2,3-dihydrofuro)-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
DK180485D0 (da) * 1985-04-22 1985-04-23 Novo Industri As Nitrogenholdige forbindelser
US4769368A (en) * 1986-02-10 1988-09-06 Smithkline Beckman Corporation 2,3,4,8,9,9A-Hexahydro-4-aryl-1H-indeno(1,7-CD)azepines
DK67489D0 (da) * 1989-02-14 1989-02-14 Novo Industri As Nye benzazepinderivater
JPH03153111A (ja) * 1989-11-09 1991-07-01 Murata Mfg Co Ltd 弾性表面波発振器
GB9903671D0 (en) * 1999-02-17 1999-04-14 Cenes Ltd Dopamine D-1 receptor agonist compounds
US6953787B2 (en) * 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
CN101792417A (zh) * 2003-06-17 2010-08-04 艾尼纳制药公司 用于治疗5ht2c受体相关疾病的苯并氮杂卓衍生物
MXPA05013364A (es) 2003-06-17 2006-03-17 Arena Pharm Inc Procedimiento para preparar 3-benzazepinas.
WO2005042491A1 (en) * 2003-10-22 2005-05-12 Arena Pharmaceuticals, Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
WO2005042490A1 (en) * 2003-10-22 2005-05-12 Arena Pharmaceuticals, Inc. Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
SI1838677T1 (sl) 2004-12-21 2010-01-29 Arena Pharm Inc Kristalne oblike (R)-8-kloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzazepin hidroklorida
EA015012B1 (ru) 2004-12-23 2011-04-29 Арена Фармасьютикалз, Инк. Композиция, содержащая фентермин и избирательный агонист рецептора 5ht, и ее применение
SG10201508066VA (en) 2006-04-03 2015-10-29 Arena Pharm Inc Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto
ES2522587T3 (es) * 2006-12-05 2014-11-17 Arena Pharmaceuticals, Inc. Procesos para preparar (R)-8-cloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzacepina e intermedios de la misma
JP4933325B2 (ja) * 2007-03-29 2012-05-16 原田工業株式会社 接続端子構造
WO2009111004A1 (en) * 2008-03-04 2009-09-11 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-ht2c agonist (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine
EP2443080A2 (en) 2009-06-18 2012-04-25 Arena Pharmaceuticals, Inc. Process for the preparation of 5-ht2c receptor agonists
WO2011153206A1 (en) 2010-06-02 2011-12-08 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
EP2611433A2 (en) 2010-09-01 2013-07-10 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-ht2c agonists
SG188365A1 (en) 2010-09-01 2013-04-30 Arena Pharm Inc Administration of lorcaserin to individuals with renal impairment
KR20180118801A (ko) 2010-09-01 2018-10-31 에자이 알앤드디 매니지먼트 가부시키가이샤 체중 관리에 유용한 5-ｈｔ2ｃ 작동제의 변형-방출 투여 형태
EP2611782A1 (en) 2010-09-01 2013-07-10 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
KR20190128001A (ko) 2012-10-09 2019-11-13 에자이 알앤드디 매니지먼트 가부시키가이샤 체중 관리 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3393192A (en) * 1965-04-26 1968-07-16 Schering Corp Novel benzazepines
US3609138A (en) * 1967-12-22 1971-09-28 Ciba Geigy Corp 1-aryl-3-benzazepines
US3663532A (en) * 1970-03-04 1972-05-16 American Home Prod Benzodiazocines

Also Published As

Publication number Publication date
US4111957A (en) 1978-09-05
JPS62161764A (ja) 1987-07-17
FR2379534A1 (fr) 1978-09-01
JPS6341912B2 (ja) 1988-08-19
GB1599705A (en) 1981-10-07
FR2383929B1 (ja) 1981-07-31
BE868868A (fr) 1979-01-10
FR2379534B1 (ja) 1981-11-27
DE2804285A1 (de) 1978-08-03
FR2383929A1 (fr) 1978-10-13
DE2804285C2 (ja) 1988-01-07

Similar Documents

Publication Publication Date Title
JPS5395989A (en) Substituted 11thienyl and furyll 2*3*4*55tetrahydroo1hh33benzazepine compound
NZ187453A (en) Benzsubstituted-1-substitutedpiperid-1'-ylphthalazines
JPS5615290A (en) 77 and 7788substituted 4*55alphaaepoxymorphinann 66one compound
JPS53108196A (en) Compound and its application
JPS53149981A (en) 3*3*33triarylalkyll44phenylalkyll44hydroxyy piperidine and its related compound
JPS549281A (en) 44aminomethyll11*3*3*33 triarylpropyl**44 arylpyperidine and derivative thereof
JPS53144592A (en) 122alkyll1*4*7*100tetrazacyclotridecane
JPS5484554A (en) 11nn4*66diioo*aminoglycocyl**1*33diamino sicritol derivatives
GB1557552A (en) 1 oxadethiacepham compounds
JPS5390280A (en) Substituted 11alkylthiophenyll 2*3*4*55tetrahydroo1hh33benzazepine compound
JPS53149987A (en) 55iodoo5**aminoo2**5**dideoxycitidine and its salt
JPS53130685A (en) 11substitutedd33amimoo6*77dialkoxyy1*2*44 benzothiadiazinee11oxides
JPS54106462A (en) 33*nnacyllnnarylamino**gammaabutyrolactone and gammaabutyrothiolactone
JPS54163581A (en) 2*22di substitutedd77substituteddchromann44 onee55carboxyaldehyde
JPS5412313A (en) Glycerylltrii3*5*55trimethylhexanoate
JPS53132582A (en) 33*11piperadinyl**1*2*44benzotriazine and nnoxide
ZA78327B (en) 4'-deoxyvincristine and related compounds
JPS5455585A (en) Novel 1*44 dihydropiridazine compound
JPS5419978A (en) 1*2*44oxadiazol derivative
JPS5398981A (en) Semiisynthesis 4**aminoooreandomycine derivative
ZA786230B (en) 8 and/or 9 substituted 2-benzazepine compounds
JPS5463095A (en) Semiisynthesized 4**ureiddoleandomycin derivative
JPS5476586A (en) 2*44diaminoo55benzylpyrimidines
JPS54106465A (en) 16*177pyrazolinoo and 16*177isopyrazolinoo 1*44pregnadiene derivative
JPS5466657A (en) 55isopropyll11oxaspiro*2*4*heptoo44ene